AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock
NASDAQ: AMRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$12.80
+0.51% today
Updated 2026-04-29
Market cap
$4.08B
P/E ratio
58.18
P/S ratio
1.35x
EPS (TTM)
$0.22
Dividend yield
—
52W range
$7 – $15
Volume
1.9M
WallStSmart proprietary scores
44
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A5.8
Quality
C+4.5
Profitability
C5.7
Valuation
C+5/9
Piotroski F-Score
Moderate
1.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$17.00
+32.81%
12-Month target
$6.77
-47.11%
Intrinsic (DCF)
$34.70
Margin of safety
+57.64%
3 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $87.15M — positive
+ Revenue growth 11.50% QoQ
+ 57.64% below intrinsic value
Risks
- Altman Z 1.13 — distress zone
- Thin margins at 2.39%
- P/E 58.18x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.21B | $2.39B | $2.79B | $3.02B | $3.02B |
| Net income | $-129.99M | $-83.99M | $-116.89M | $72.06M | $-15.74M |
| EPS | — | — | — | — | $0.22 |
| Free cash flow | $-25.50M | $276.39M | $220.11M | $269.93M | $87.15M |
| Profit margin | -5.88% | -3.51% | -4.18% | 2.39% | 2.39% |
Peer comparison
Smart narrative
Amneal Pharmaceuticals, Inc. Class A Common Stock trades at $12.80. representing a P/E of 58.18x trailing earnings. Our Smart Value Score of 44/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.13, it sits in the distress. TTM revenue stands at $3.02B. with profit margins at 2.39%. Our DCF model estimates intrinsic value at $34.70.
Frequently asked questions
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's stock price?
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) trades at $12.80.
Is Amneal Pharmaceuticals, Inc. Class A Common Stock overvalued?
Smart Value Score 44/100 (Grade D, Sell). DCF value $34.70.
What is the price target of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)?
The analyst target price is $17.00, representing +32.8% upside from the current price of $12.80.
What is the intrinsic value of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)?
Based on our DCF model, intrinsic value is $34.70, a +57.6% margin of safety versus $12.80.
What is Amneal Pharmaceuticals, Inc. Class A Common Stock's revenue?
TTM revenue is $3.02B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
1.13 — distress.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.35x
ROE-881.00%
Beta1.32
50D MA$12.96
200D MA$11.53
Shares out0.32B
Float0.18B
Short ratio—
Avg volume1.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—